https://charts.traderzeitung.de/phases/US77313F1066
string(1442) "{"isin":"US77313F1066","name":"Rocket Pharmaceuticals Inc","stock_id_xnas":7874861,"stock_id_xnys":null,"generated_at":"2026-07-21 03:47:00","days":[{"date":"2026-07-16","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.41,"close_at":"2026-07-16 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":3.405,"close_at":"2026-07-16 23:49:00","complete":true,"perf_pct":-0.1466}]},{"date":"2026-07-17","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":3.39,"close_at":"2026-07-17 15:04:00","complete":true,"perf_pct":-0.4405},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.435,"close_at":"2026-07-17 21:59:00","complete":true,"perf_pct":1.3274},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-20","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.42,"close_at":"2026-07-20 21:59:00","complete":true,"perf_pct":-0.4367},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Rocket Pharmaceuticals Aktie News & Nachrichten
Trading-Room

Rocket Pharmaceuticals Aktie News & Nachrichten

[WKN: A2JA9Q | Symbol: RCKT]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel
Rocket Pharmaceuticals Chart

Artikel aus der Redaktion der Trader-Zeitung

Rocket Pharmaceuticals

TOP-5-Kursziele der Analysten am 12.03.25

Rocket Pharmaceuticals [US77313F1066]: BMO Capital startet Berichterstattung mit einem Overweight-Rating...

TOP-5-Kursziele der Analysten am 18.12.24

Bechtle AG [DE0005158703]: Jefferies bekräftigt das Anlagevotum "Buy" mit Kursziel 50 Euro (60 % Kurspotenzial)...

  • ‹
  • 1
  • ›
Rocket Pharmaceuticals Nachrichtenticker öffnen
MT Newswires 12.06.2026 15:23 Uhr

Sektor-Update: Gesundheitsaktien legen vorbörslich am Freitag zu

09:22 AM EDT, 06/12/2026 (MT Newswires) -- Gesundheitsaktien legten vorbörslich am Freitag zu, wobei der State Street Health Care Select Sector SPDR E

MT Newswires 12.06.2026 13:50 Uhr

Rocket Pharmaceuticals vollzieht den Verkauf eines pädiatrischen Priority Review Vouchers für 180 Millionen US-Dollar

07:49 AM EDT, 06/12/2026 (MT Newswires) -- Rocket Pharmaceuticals (RCKT) hat den Verkauf ihres Priority Review Vouchers für seltene pädiatrische Krank